RSV Vaccine Approved by FDA for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]
U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection
The Biden administration announced earlier this month that the U.S. government will spend at least $5 billion on Project NextGen to rapidly develop “next-generation” SARS-CoV-2 vaccines and treatments despite evidence that current COVID vaccines do not prevent infection and transmission of the new coronavirus.1 Following a similar approach to “Operation Warp Speed” initiated by the […]
Pfizer Hid Data on Waning Immunity
In late 2020, the airways became saturated with triumphant reporting of Pfizer and Moderna’s “95% effective” COVID-19 vaccines. Millions rolled up their sleeves with the belief that reaching herd immunity would end the pandemic. But by June 2021, the pandemic endgame story had gone off script. Highly vaccinated countries like Israel were experiencing a new wave of […]
Global Pediatric Vaccines Market to Exceed $69 Billion by 2030
A report released by Coherent Market Insights showed that pediatric vaccines market will surpass $69.482 billion by 2030.1 The main pharmaceutical companies in the global market for pediatric vaccines include Bharat Biotech, Emergent BioSolutions, GSK, Indian Immunologicals, Merck, Panacea Biotec, Pfizer, Sanofi, Serum Institute and Zydus Cadila.2 Pediatric Vaccine Approvals by Governments Will Drive Vaccine […]
The mRNA Platform: What It Is, What It Means
Back in the spring of 2020 we learned that Operation Warp Speed was hard at work creating a vaccine faster than one had ever been created before. From the decades-long history of vaccine development, we knew that vaccines took five to 10 years to make. The subsequent clinical trials could take longer. How was this […]
Women 3.5 Times More Likely to Develop Heart Disease or Die Suddenly After AstraZeneca COVID Vaccine
A new report shows that women aged 12-29 who received AstraZeneca/Oxford University’s Vaxzevria adenovirus vectored COVID-19 vaccine are three and a half times more likely to develop heart disease, suffer sudden death, or both, in the 12 days post vaccination.1 The statistical model linked 11 out of 15 cardiac deaths directly to Vaxzevria, also citing […]